Calithera Biosciences, Inc.
CALA
$0.0001
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 89.98% | 12.26% | 36.57% | 32.16% | -206.70% |
| Total Depreciation and Amortization | 0.00% | -10.14% | -12.33% | -12.33% | -20.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.56% | -40.87% | -133.71% | -45.92% | 1,797.47% |
| Change in Net Operating Assets | -3,456.63% | -50.61% | -681.74% | 15.46% | 102.95% |
| Cash from Operations | 66.38% | -1.72% | -1.29% | 27.23% | -11.18% |
| Capital Expenditure | 41.03% | 100.00% | -- | -- | -8.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 41.03% | 100.00% | -107.33% | -- | -100.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.52% | 1,400.00% | 1,689.26% | -88.08% | 65.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.39% | 1,400.00% | 1,689.26% | -88.08% | 31.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.47% | -0.12% | 68.57% | -149.34% | -85.74% |